Our findings reveal that pre-NAT tumor vascularity on color CDFI, post-NAT CDFI patterns, and their longitudinal changes significantly influence ypN0 attainment in HER2-positive breast cancer. This evidence concerns the gene ERBB2 and breast cancer.